Chemours (NYSE:CC – Free Report) had its target price lowered by Royal Bank of Canada from $30.00 to $28.00 in a research note issued to investors on Monday morning, Benzinga reports. The brokerage currently has a sector perform rating on the specialty chemicals company’s stock. Other equities research analysts have also issued research reports about […]
Chemours (NYSE:CC – Get Free Report) had its price objective lowered by research analysts at Morgan Stanley from $33.00 to $28.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage presently has an “equal weight” rating on the specialty chemicals company’s stock. Morgan Stanley’s target price points to a potential upside […]
Chemours (NYSE:CC – Get Free Report) had its target price decreased by research analysts at Barclays from $31.00 to $28.00 in a research note issued on Monday, Benzinga reports. The brokerage presently has an “equal weight” rating on the specialty chemicals company’s stock. Barclays‘s price objective would indicate a potential upside of 15.99% from the […]
Chemours (NYSE:CC – Get Free Report) had its price target reduced by equities researchers at Barclays from $31.00 to $28.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage presently has an “equal weight” rating on the specialty chemicals company’s stock. Barclays‘s target price points to a potential upside of 15.99% […]
Chemours (NYSE:CC – Get Free Report) had its price objective lowered by equities researchers at Morgan Stanley from $33.00 to $28.00 in a note issued to investors on Monday, Benzinga reports. The brokerage currently has an “equal weight” rating on the specialty chemicals company’s stock. Morgan Stanley’s target price would indicate a potential upside of […]